• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非甾体抗炎药对充血性心力衰竭患者的不良心血管影响。

Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure.

作者信息

Feenstra J, Grobbee D E, Mosterd A, Stricker B H

机构信息

Department of Epidemiology and Biostatistics, Erasmus University Medical School Rotterdam, The Netherlands.

出版信息

Drug Saf. 1997 Sep;17(3):166-80. doi: 10.2165/00002018-199717030-00003.

DOI:10.2165/00002018-199717030-00003
PMID:9306052
Abstract

Congestive heart failure (CHF) is a complex clinical syndrome, especially in the elderly, which results from cardiac dysfunction. Epidemiological studies have shown a gradual increase in age-adjusted hospitalisation rates for CHF and overall population prevalence of CHF during the last 2 decades in Western countries. The healthcare costs associated with CHF are considerable and are likely to increase in the near future. Hence, identification of risk factors which could induce or exacerbate CHF is of major importance. NSAIDs are frequently prescribed in elderly patients for several rheumatological and nonrheumatological indications. Numerous adverse reactions, mainly related to the gastrointestinal tract and kidney function, have been described for NSAIDs. In addition, some case reports have suggested a causal relation between the use of NSAIDs and the onset of CHF. The pathophysiology of CHF and the pharmacological properties of NSAIDs support this hypothesis. In particular, the inhibition of prostaglandin synthesis may adversely affect cardiovascular homeostasis in patients with a propensity to develop CHF. Notwithstanding the adverse effects, however, the prescription of NSAIDs in elderly patients is often desirable and justifiable. Therefore, further pharmaco-epidemiological research is needed to quantify the risk for CHF attributable to the use of NSAIDs and to identify patients who are particularly susceptible to the adverse cardiovascular effects of these agents. In these patients, it may be advisable to avoid the use of NSAIDs.

摘要

充血性心力衰竭(CHF)是一种复杂的临床综合征,在老年人中尤为如此,它由心脏功能障碍引起。流行病学研究表明,在过去20年中,西方国家经年龄调整的CHF住院率和CHF在总人口中的患病率都在逐渐上升。与CHF相关的医疗费用相当可观,而且在不久的将来可能还会增加。因此,识别可能诱发或加重CHF的危险因素至关重要。非甾体抗炎药(NSAIDs)经常被开给老年患者用于多种风湿性和非风湿性适应症。NSAIDs有许多不良反应,主要与胃肠道和肾功能有关。此外,一些病例报告表明NSAIDs的使用与CHF的发病之间存在因果关系。CHF的病理生理学和NSAIDs的药理特性支持这一假设。特别是,前列腺素合成的抑制可能会对有发生CHF倾向的患者的心血管稳态产生不利影响。然而,尽管有这些不良反应,但在老年患者中使用NSAIDs往往是必要且合理的。因此,需要进一步开展药物流行病学研究,以量化因使用NSAIDs导致CHF的风险,并识别出对这些药物的不良心血管影响特别敏感的患者。对于这些患者,避免使用NSAIDs可能是明智的。

相似文献

1
Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure.非甾体抗炎药对充血性心力衰竭患者的不良心血管影响。
Drug Saf. 1997 Sep;17(3):166-80. doi: 10.2165/00002018-199717030-00003.
2
Nonsteroidal anti-inflammatory drugs and heart failure.非甾体抗炎药与心力衰竭
Drugs. 2003;63(6):525-34. doi: 10.2165/00003495-200363060-00001.
3
Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.非甾体抗炎药的使用与老年患者充血性心力衰竭的发生:一个未得到充分认识的公共卫生问题。
Arch Intern Med. 2000 Mar 27;160(6):777-84. doi: 10.1001/archinte.160.6.777.
4
NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics.在服用利尿剂的老年患者中,非甾体抗炎药会增加充血性心力衰竭的风险。
Arch Intern Med. 1998 May 25;158(10):1108-12. doi: 10.1001/archinte.158.10.1108.
5
Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications.非甾体抗炎药的肾毒性:生理基础与临床意义
Am J Med. 1999 May 31;106(5B):13S-24S. doi: 10.1016/s0002-9343(99)00113-8.
6
Nonsteroidal anti-inflammatory drugs in patients with cardio- or cerebrovascular disorders.患有心脑血管疾病患者使用非甾体抗炎药的情况。
Z Kardiol. 2003 Sep;92(9):721-9. doi: 10.1007/s00392-003-0964-x.
7
[Trends in pharmacological treatment of congestive heart failure].[充血性心力衰竭的药物治疗趋势]
Pol Merkur Lekarski. 1999 Mar;6(33):152-6.
8
Anti-inflammatory agents and renal function.抗炎药与肾功能
Semin Arthritis Rheum. 2002 Dec;32(3 Suppl 1):33-42. doi: 10.1053/sarh.2002.37216.
9
Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly?环氧化酶-2抑制剂:老年人何时应使用它们?
Drugs Aging. 2005;22(3):185-200. doi: 10.2165/00002512-200522030-00001.
10
Drugs, heart failure and quality of life: what are we achieving? What should we be trying to achieve?药物、心力衰竭与生活质量:我们取得了哪些成果?我们应努力实现什么目标?
Drugs Aging. 1999 Mar;14(3):153-63. doi: 10.2165/00002512-199914030-00001.

引用本文的文献

1
Coronary Risks Associated with Diclofenac and Other NSAIDs: An Update.与双氯芬酸和其他 NSAIDs 相关的冠心病风险:最新进展。
Drug Saf. 2020 Apr;43(4):301-318. doi: 10.1007/s40264-019-00900-8.
2
Adverse drug reaction-related hospitalisations among patients with heart failure at two hospitals in the United Arab Emirates.阿拉伯联合酋长国两家医院中心力衰竭患者中与药物不良反应相关的住院情况。
Int J Clin Pharm. 2015 Feb;37(1):105-12. doi: 10.1007/s11096-014-0046-3. Epub 2014 Dec 9.
3
Paracetamol: new vistas of an old drug.对乙酰氨基酚:一种老药的新前景。

本文引用的文献

1
The epidemiology of heart failure.心力衰竭的流行病学
Eur Heart J. 1997 Feb;18(2):208-25. doi: 10.1093/oxfordjournals.eurheartj.a015223.
2
Vascular effects of loop diuretics.
Cardiovasc Res. 1996 Dec;32(6):988-97. doi: 10.1016/s0008-6363(96)00134-4.
3
Meloxicam.美洛昔康
Drugs. 1996 Mar;51(3):424-30; discussion 431-32. doi: 10.2165/00003495-199651030-00007.
CNS Drug Rev. 2006 Fall-Winter;12(3-4):250-75. doi: 10.1111/j.1527-3458.2006.00250.x.
4
Heart failure induced by non-cardiac drugs.非心脏药物所致的心力衰竭
Drug Saf. 2006;29(7):567-86. doi: 10.2165/00002018-200629070-00003.
5
Does aspirin attenuate the beneficial effect of ACE inhibitors in elderly people with heart failure?阿司匹林会减弱血管紧张素转换酶抑制剂对老年心力衰竭患者的有益作用吗?
Drugs Aging. 2005;22(7):605-14. doi: 10.2165/00002512-200522070-00006.
6
NS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis.NS-398,一种环氧化酶-2特异性抑制剂,通过减少再生和促进纤维化来延缓骨骼肌愈合。
Am J Pathol. 2005 Oct;167(4):1105-17. doi: 10.1016/S0002-9440(10)61199-6.
7
Changes in drug treatment in the elderly between 1971 and 2000.1971年至2000年间老年人药物治疗的变化。
Eur J Clin Pharmacol. 2003 Nov;59(8-9):637-44. doi: 10.1007/s00228-003-0647-6. Epub 2003 Aug 16.
8
Nonsteroidal anti-inflammatory drugs and heart failure.非甾体抗炎药与心力衰竭
Drugs. 2003;63(6):525-34. doi: 10.2165/00003495-200363060-00001.
4
General pharmacology of meloxicam--Part I: Effects on CNS, gastric emptying, intestinal transport, water, electrolyte and creatinine excretion.
Gen Pharmacol. 1996 Jun;27(4):673-7. doi: 10.1016/0306-3623(95)02034-9.
5
The renal effects of nonsteroidal anti-inflammatory drugs: summary and recommendations.非甾体抗炎药的肾脏效应:总结与建议
Am J Kidney Dis. 1996 Jul;28(1 Suppl 1):S56-62. doi: 10.1016/s0272-6386(96)90570-3.
6
Congestive heart failure with normal left ventricular systolic function. Clinical approaches to the diagnosis and treatment of diastolic heart failure.左心室收缩功能正常的充血性心力衰竭。舒张性心力衰竭的诊断与治疗临床方法。
Arch Intern Med. 1996 Jan 22;156(2):146-57.
7
Meloxicam: influence on arachidonic acid metabolism. Part II. In vivo findings.美洛昔康:对花生四烯酸代谢的影响。第二部分。体内研究结果。
Biochem Pharmacol. 1996 Jan 12;51(1):29-38. doi: 10.1016/0006-2952(95)02110-8.
8
Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group.射血分数、运动峰值耗氧量、心胸比率、室性心律失常及血浆去甲肾上腺素作为心力衰竭预后的决定因素。V-HeFT VA合作研究组。
Circulation. 1993 Jun;87(6 Suppl):VI5-16.
9
Non-steroidal anti-inflammatory drugs and angiotensin converting enzyme inhibitors: a commonly prescribed combination with variable effects on renal function.非甾体抗炎药与血管紧张素转换酶抑制剂:一种常用组合,对肾功能有不同影响。
Br J Clin Pharmacol. 1993 Apr;35(4):343-8. doi: 10.1111/j.1365-2125.1993.tb04149.x.
10
Diastolic dysfunction as a cause of heart failure.
J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):49A-55A. doi: 10.1016/0735-1097(93)90463-b.